Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants.
Jiang L, Driedonks TAP, Jong WSP, Dhakal S, Bart van den Berg van Saparoea H, Sitaras I, Zhou R, Caputo C, Littlefield K, Lowman M, Chen M, Lima G, Gololobova O, Smith B, Mahairaki V, Riley Richardson M, Mulka KR, Lane AP, Klein SL, Pekosz A, Brayton C, Mankowski JL, Luirink J, Villano JS, Witwer KW. Jiang L, et al. Among authors: sitaras i. J Extracell Vesicles. 2022 Mar;11(3):e12192. doi: 10.1002/jev2.12192. J Extracell Vesicles. 2022. PMID: 35289114 Free PMC article.
A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients.
Karaba AH, Zhu X, Liang T, Wang KH, Rittenhouse AG, Akinde O, Eby Y, Ruff JE, Blankson JN, Abedon AT, Alejo JL, Cox AL, Bailey JR, Thompson EA, Klein SL, Warren DS, Garonzik-Wang JM, Boyarsky BJ, Sitaras I, Pekosz A, Segev DL, Tobian AAR, Werbel WA. Karaba AH, et al. Among authors: sitaras i. medRxiv [Preprint]. 2021 Oct 13:2021.08.11.21261914. doi: 10.1101/2021.08.11.21261914. medRxiv. 2021. PMID: 34671774 Free PMC article. Updated. Preprint.
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients.
Karaba AH, Zhu X, Liang T, Wang KH, Rittenhouse AG, Akinde O, Eby Y, Ruff JE, Blankson JN, Abedon AT, Alejo JL, Cox AL, Bailey JR, Thompson EA, Klein SL, Warren DS, Garonzik-Wang JM, Boyarsky BJ, Sitaras I, Pekosz A, Segev DL, Tobian AAR, Werbel WA. Karaba AH, et al. Among authors: sitaras i. Am J Transplant. 2022 Apr;22(4):1253-1260. doi: 10.1111/ajt.16933. Epub 2022 Jan 18. Am J Transplant. 2022. PMID: 34951746 Free PMC article.
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection.
Park HS, Shapiro JR, Sitaras I, Woldemeskel BA, Garliss CC, Dziedzic A, Sachithanandham J, Jedlicka AE, Caputo CA, Rousseau KE, Thakar M, Suwanmanee S, Hauk P, Aliyu L, Majewska NI, Koley S, Patel B, Broderick P, Mosnaim G, Heath SL, Spivak ES, Shenoy A, Bloch EM, Gniadek TJ, Shoham S, Casadevall A, Hanley D, Cox AL, Laeyendecker O, Betenbaugh MJ, Cramer SM, Mostafa HH, Pekosz A, Blankson JN, Klein SL, Tobian AA, Sullivan D, Gebo KA. Park HS, et al. Among authors: sitaras i. JCI Insight. 2022 Mar 8;7(5):e155944. doi: 10.1172/jci.insight.155944. JCI Insight. 2022. PMID: 35104245 Free PMC article.
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants.
Jiang L, Driedonks TAP, Jong WSP, Dhakal S, van den Berg van Saparoea HB, Sitaras I, Zhou R, Caputo C, Littlefield K, Lowman M, Chen M, Lima G, Gololobova O, Smith B, Mahairaki V, Richardson MR, Mulka KR, Lane AP, Klein SL, Pekosz A, Brayton CF, Mankowski JL, Luirink J, Villano JS, Witwer KW. Jiang L, et al. Among authors: sitaras i. bioRxiv [Preprint]. 2022 Feb 1:2021.06.28.450181. doi: 10.1101/2021.06.28.450181. bioRxiv. 2022. PMID: 35132418 Free PMC article. Updated. Preprint.
Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine-Induced Immunity in Older Adults.
Shapiro JR, Sitaras I, Park HS, Aytenfisu TY, Caputo C, Li M, Lee J, Johnston TS, Li H, Wouters C, Hauk P, Jacobsen H, Li Y, Abrams E, Yoon S, Kocot AJ, Yang T, Huang Y, Cramer SM, Betenbaugh MJ, Debes AK, Morgan R, Milstone AM, Karaba AH, Pekosz A, Leng SX, Klein SL. Shapiro JR, et al. Among authors: sitaras i. Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S61-S71. doi: 10.1093/cid/ciac397. Clin Infect Dis. 2022. PMID: 35607747 Free PMC article.
Post-vaccination T cell immunity to omicron.
Jacobsen H, Cobos Jiménez V, Sitaras I, Bar-Zeev N, Čičin-Šain L, Higdon MM, Deloria-Knoll M. Jacobsen H, et al. Among authors: sitaras i. Front Immunol. 2022 Jul 26;13:944713. doi: 10.3389/fimmu.2022.944713. eCollection 2022. Front Immunol. 2022. PMID: 35990661 Free PMC article. Review.
Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients.
Karaba AH, Kim JD, Chiang TP, Alejo JL, Sitaras I, Abedon AT, Eby Y, Johnston TS, Li M, Aytenfisu T, Hussey C, Jefferis A, Fortune N, Abedon R, Thomas L, Habtehyimer F, Ruff J, Warren DS, Avery RK, Clarke WA, Pekosz A, Massie AB, Tobian AAR, Segev DL, Werbel WA. Karaba AH, et al. Among authors: sitaras i. Am J Transplant. 2023 Mar;23(3):423-428. doi: 10.1016/j.ajt.2022.11.002. Epub 2023 Jan 12. Am J Transplant. 2023. PMID: 36906295 Free PMC article.
28 results